source
- Beeline Medicines secures $126M from Bain Capital, CPPIB and Bristol Myers to expand immunology pipelineBeeline Medicines, a spinout from Bristol Myers Squibb, announced it has received an additional $126 million in financing. The new capital comes from existing investors Bain Capital and the Canada…
- Trump drug deal with Eli Lilly and Novo Nordisk has loophole allowing higher GLP-1 volumes without price cutsThe Trump administration negotiated a "grand bargain" with drugmakers that promised lower Medicare and Medicaid prices for GLP‑1 drugs in exchange for higher sales volume. Eli Lilly and Novo Nordi…